Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
Eligible age
24+ yrs
Accepts
Women
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a large, prospective, single-arm cohort study of transvaginal ultrasonographic screening for ovarian cancer in intermediate to high-risk women from Kentucky. Detection of ovarian malignancy often occurs subsequent to the initial transvaginal sonography (TVS) screen; therefore, it is important to offer continued screening to study participants based on our published algorithm. Screening will be available to participants for as long as they elect to receive it. The primary study endpoints are to determine if prospective serial transvaginal ultrasonography can decrease the false-positive (FP) percentage and improve the positive predictive value (PPV) as suggested by retrospective analysis without compromising the detection of true positives or promote the occurrence of false negatives.
Sponsor: John R van Nagell
You may qualify if…
- ✓ women over the age of 50 years;
- ✓ women with a documented family history of ovarian cancer over the age of 24 years;
- ✓ women over the age of 24 years with a personal history of breast cancer
- ✓ ECOG performance status of 0 to 2.34
- ✓ Subjects having undergone prior hysterectomy will be eligible provided that they meet the other requirements for entry into this study and have at least one ovary.
- ✓ Ability to understand and the willingness to sign a written informed consent document.
You may not qualify if…
- ✕ Women who are referred with pelvic symptoms, a known pelvic mass or a history of prior radiation.
- ✕ Individuals that cannot safely receive transvaginal ultrasound due to vaginal size, vaginal infections, lack of bowel or bladder control or inability to physically place their body in position to receive transvaginal ultrasound
- ✕ Prisoners
- ✕ Pregnant women
- ✕ Women with a prior history of ovarian cancer
- ✕ Exclusions will apply to anyone who presents with factors or issues that prevent them from understanding the screening research procedures or completing the informed consent component or personal information needed for the study
Where it's recruiting
Lexington
Source: ClinicalTrials.gov · NCT04473833 · last updated 2025-11-14